Huron Consulting Group Inc. (NASDAQ:HURN) Director Sells $252,060.00 in Stock

Huron Consulting Group Inc. (NASDAQ:HURN) Director James H. Roth sold 2,000 shares of the business’s stock in a transaction dated Wednesday, February 5th. The shares were sold at an average price of $126.03, for a total value of $252,060.00. Following the completion of the transaction, the director now directly owns 48,534 shares of the company’s stock, valued at approximately $6,116,740.02. This trade represents a 3.96 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

Huron Consulting Group Stock Performance

HURN traded down $0.43 during mid-day trading on Friday, reaching $126.14. 6,751 shares of the company traded hands, compared to its average volume of 88,970. The company’s fifty day moving average price is $124.42 and its 200-day moving average price is $115.49. The stock has a market capitalization of $2.24 billion, a P/E ratio of 27.46 and a beta of 0.59. Huron Consulting Group Inc. has a 52-week low of $84.26 and a 52-week high of $133.96. The company has a quick ratio of 1.61, a current ratio of 1.61 and a debt-to-equity ratio of 0.82.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of HURN. Quest Partners LLC lifted its stake in Huron Consulting Group by 131.9% in the third quarter. Quest Partners LLC now owns 13,814 shares of the business services provider’s stock worth $1,502,000 after acquiring an additional 7,858 shares during the period. Wellington Management Group LLP raised its stake in Huron Consulting Group by 29.1% in the 3rd quarter. Wellington Management Group LLP now owns 538,290 shares of the business services provider’s stock worth $58,512,000 after acquiring an additional 121,371 shares during the last quarter. Franklin Resources Inc. boosted its position in Huron Consulting Group by 20.5% in the third quarter. Franklin Resources Inc. now owns 395,788 shares of the business services provider’s stock valued at $42,306,000 after buying an additional 67,239 shares during the last quarter. Atom Investors LP acquired a new stake in shares of Huron Consulting Group in the third quarter worth $1,159,000. Finally, Natixis Advisors LLC raised its stake in shares of Huron Consulting Group by 32.7% during the 3rd quarter. Natixis Advisors LLC now owns 18,571 shares of the business services provider’s stock valued at $2,019,000 after buying an additional 4,576 shares during the last quarter. Institutional investors own 93.90% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have weighed in on the company. Wedbush started coverage on Huron Consulting Group in a research note on Monday. They set an “outperform” rating for the company. StockNews.com raised Huron Consulting Group from a “hold” rating to a “buy” rating in a research report on Thursday, October 31st. Benchmark restated a “buy” rating and issued a $140.00 price target on shares of Huron Consulting Group in a research report on Wednesday, October 30th. Finally, Barrington Research raised their target price on Huron Consulting Group from $137.00 to $142.00 and gave the stock an “outperform” rating in a research note on Monday, November 4th. Five investment analysts have rated the stock with a buy rating, According to MarketBeat.com, the company has a consensus rating of “Buy” and an average price target of $133.00.

Huron Consulting Group Company Profile

Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children’s and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.